Towards Healthcare
Pharmaceutical Stability & Storage Services Market to Drive USD 5.92 Bn by 2034

Pharmaceutical Stability & Storage Services Market Expansion Driven by AI & Biologics

Projections indicate that, the global pharmaceutical stability & storage services market will increase from USD 3.4 billion in 2024 to USD 5.92 billion by 2034, experiencing a CAGR of 5.7% over the next 10 years. The compliance with global standards and the effectiveness of scientific quality assurance raise the importance of pharmaceuticals. North America dominated the market in 2024, driven by strict FDA and regional regulations and complex drug formulations.

  • Insight Code: 6192
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: September 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Shivani Zoting is a dedicated research analyst specializing in the healthcare industry. With a strong academic foundation, a B.Sc. in Biotechnology and an MBA in Pharmabiotechnology, she brings a unique blend of scientific understanding and market strategy to her research.

Shivani contributes to Towards Healthcare and plays an active role at Precedence Research, where she focuses on delivering in-depth market intelligence, competitive analysis, and trend forecasting across pharmaceuticals, medical devices, digital health, and healthcare services. Her insights support healthcare companies, investors, and policymakers in making data-backed decisions in a highly regulated and rapidly evolving sector.

Additionally, Shivani collaborates with Statifacts, further expanding her healthcare domain reach by engaging in diverse projects across global markets. Her strength lies in transforming complex clinical and commercial data into strategic narratives that help stakeholders navigate the future of healthcare.

FAQ's

The pharmaceutical stability & storage services market currently in 2025 records USD 3.59 billion and is anticipated to grow to USD 5.92 billion by 2034, advancing at a CAGR of 5.7% from 2024 to 2034.

North America is currently leading the pharmaceutical stability & storage services market share 42% due to strict compliance standards and the rise of biologics and biosimilars.

Some key players include Thermo Fisher Scientific Inc., Charles River Laboratories, and Catalent Inc.

Ministry of Health and Family Welfare, Government of India, National Institutes of Health, FDA, WHO, PIB, CDC.